Urease-IN-22
Urease-IN-22 (Compound 9L) is a Urease inhibitor with an IC50 of 0.15 μM. Urease-IN-22 is a piperazine-based derivative of Benzimidazole (HY-Y1825) [1].
Product Specifications
UNSPSC
12352100
Target
Urease
Related Pathways
Anti-infection
Field of Research
Others
Smiles
COC1=CC(C2=NC3=C(N2)C=CC(C(N4CCN(CC4)C5=CC=CC=C5)=O)=C3)=CC=C1OCC(NC6=CC([N+]([O-])=O)=CC=C6)=O
Molecular Formula
C33H30N6O6
Molecular Weight
606.63
References & Citations
[1]Shahriarynejad D, et al. Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies. Sci Rep. 2025 Aug 9;15 (1) :29220.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1408721-01 0.02 mg (E-Coli)
Recombinant Human Placenta-specific 1-like protein (PLAC1L)
Ask
View Details MBS1408721-02 0.1 mg (E-Coli)
Recombinant Human Placenta-specific 1-like protein (PLAC1L)
Ask
View Details 
MBS1408721-03 0.02 mg (Yeast)
Recombinant Human Placenta-specific 1-like protein (PLAC1L)
Ask
View Details 
MBS1408721-04 0.1 mg (Yeast)
Recombinant Human Placenta-specific 1-like protein (PLAC1L)
Ask
View Details MBS1408721-05 0.02 mg (Baculovirus)
Recombinant Human Placenta-specific 1-like protein (PLAC1L)
Ask
View Details 
MBS1408721-06 0.02 mg (Mammalian-Cell)
Recombinant Human Placenta-specific 1-like protein (PLAC1L)
Ask
View Details